Investigation of the Clinical Usefullness of Leukocytapheresis on Rheumatoid Arthritis Resistant to or Failed With the Other Treatments.

Japanese Journal of Clinical Immunology
doi 10.2177/jsci.32.499
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Japan Society for Clinical Immunology

Related search

Experience With Tofacitinib in the Treatment of Resistant Rheumatoid Arthritis

Modern Rheumatology Journal
2015English

Structured Approach to the Investigation of Anaemia in Patients With Rheumatoid Arthritis.

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
1992English

Biologic Treatments for Rheumatoid Arthritis

Trends in Urology & Men's Health
2019English

Fri0609 European Medicines Agency's Guideline on the Clinical Investigation of Medicinal Products for the Treatment of Rheumatoid Arthritis

2018English

Clinical Evaluation of Feprazone on Rheumatoid Arthritis by the Group

Japanese Journal of Clinical Pharmacology and Therapeutics
Pharmacology
1979English

A Comparison of Prednisolone With Aspirin or Other Analgesics in the Treatment of Rheumatoid Arthritis: M. R. C. Report

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
1959English

It Is the Best of Treatments, It Is the Worst of Treatments: The Continuing Love-Hate Relationship With Glucocorticoids in Rheumatoid Arthritis

Arthritis Care and Research
Rheumatology
2017English

Clinical Application of Transfer Factor to Juvenile Rheumatoid Arthritis and Rheumatoid Arthritis in a Adult

The KITAKANTO Medical Journal
1976English

Pms5 - A Network Meta-Analysis to Evaluate the Efficacy of Baricitinib and Other Treatments of Rheumatoid Arthritis in Patients Who Are Inadequate Responders to Methotrexate

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy